Group 3 innate lymphoid cells (ILC3) are the major subset of gut-resident ILC with essential roles in infections and tissue repair, but how they adapt to the gut environment to maintain tissue residency is unclear. We report that Tox2 is critical for gut ILC3 maintenance and function. Gut ILC3 highly expressed Tox2, and depletion of Tox2 markedly decreased ILC3 in gut but not at central sites, resulting in defective control of Citrobacter rodentium infection. Single-cell transcriptional profiling revealed decreased expression of Hexokinase-2 in Tox2-deficient gut ILC3. Consistent with the requirement for hexokinases in glycolysis, Tox2-/- ILC3 displayed decreased ability to utilize glycolysis for protein translation. Ectopic expression of Hexokinase-2 rescued Tox2-/- gut ILC3 defects. Hypoxia and interleukin (IL)-17A each induced Tox2 expression in ILC3, suggesting a mechanism by which ILC3 adjusts to fluctuating environments by programming glycolytic metabolism. Our results reveal the requirement for Tox2 to support the metabolic adaptation of ILC3 within the gastrointestinal tract.
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets IFN gamma
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD45R (B220)
View all literature mentionsThis monoclonal targets IL-17A
View all literature mentionsThis monoclonal targets IL-22
View all literature mentionsThis recombinant monoclonal targets Hexokinase II
View all literature mentionsThis recombinant monoclonal targets Human Hexokinase 1
View all literature mentionsThis monoclonal targets HIF1A
View all literature mentionsThis monoclonal targets EOMES
View all literature mentionsThis monoclonal targets Gata-3
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets Gata-3
View all literature mentionsThis monoclonal targets T-bet
View all literature mentionsThis monoclonal targets Mouse RORγt
View all literature mentionsThis monoclonal targets CD45R
View all literature mentionsThis monoclonal targets CD49b (Integrin alpha 2)
View all literature mentionsThis monoclonal targets CD49a
View all literature mentionsThis monoclonal targets CD196
View all literature mentionsThis monoclonal targets CD3e
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsThis monoclonal targets Integrin alpha 4 beta 7 (LPAM-1)
View all literature mentionsThis monoclonal targets Integrin alpha 4 beta 7 (LPAM-1)
View all literature mentionsThis monoclonal targets CD135 (FLT3)
View all literature mentionsThis monoclonal targets CD5
View all literature mentionsThis monoclonal targets Ly-6A/E (Sca-1)
View all literature mentionsThis monoclonal targets NK1.1
View all literature mentionsThis monoclonal targets NK1.1
View all literature mentionsThis monoclonal targets CD90.2
View all literature mentionsThis monoclonal targets CD90.2
View all literature mentionsThis monoclonal targets CD197 (CCR7)
View all literature mentionsThis monoclonal targets CD335 (NKp46)
View all literature mentionsThis monoclonal targets CD45.1
View all literature mentionsThis monoclonal targets CD45.2
View all literature mentionsThis monoclonal targets CD45.2
View all literature mentionsThis monoclonal targets CD45.1
View all literature mentionsThis monoclonal targets CD45.2
View all literature mentionsThis monoclonal targets CD326
View all literature mentionsThis monoclonal targets NK1.1
View all literature mentionsThis monoclonal targets CD326
View all literature mentionsThis monoclonal targets KLRG1
View all literature mentionsThis monoclonal targets CD326
View all literature mentionsThis monoclonal targets CD127
View all literature mentionsThis monoclonal targets CD335
View all literature mentionsThis monoclonal targets CD117 (c-Kit)
View all literature mentionsThis monoclonal targets CD117 (c-Kit)
View all literature mentionsThis unknown targets Biotin
View all literature mentionsThis monoclonal targets CD335 (NKp46)
View all literature mentionsThis monoclonal targets KLRG1
View all literature mentionsThis monoclonal targets CD5
View all literature mentionsThis monoclonal targets TCR beta
View all literature mentionsThis monoclonal targets TCR gamma/delta
View all literature mentionsThis monoclonal targets CD8 beta
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets Ly-6G/Ly-6C
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD3e
View all literature mentionsThis monoclonal targets NK1.1
View all literature mentionsThis monoclonal targets CD45R (B220)
View all literature mentionsThis recombinant monoclonal targets Ly-6D
View all literature mentionsThis monoclonal targets TER-119
View all literature mentionsMus musculus with name B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J from IMSR.
View all literature mentionsMus musculus with name B6.129-Hif1atm3Rsjo/J from IMSR.
View all literature mentions